1Department of Public Health, Universitas Negeri Manado, Indonesia
2Sam Ratulangi General Hospital, Indonesia
BibTex Citation Data :
@article{JBTR22185, author = {Lucyana Pongoh and Jonesius Manoppo and Gerry Supit and Alva Supit}, title = {Complex interaction between allopurinol-induced uric acid reduction and glycemic control: a clinical and molecular study}, journal = {Journal of Biomedicine and Translational Research}, volume = {10}, number = {3}, year = {2024}, keywords = {allopurinol; diabetes mellitus; insulin resistance; hyperuricemia; Glut4}, abstract = { Background : Diabetes mellitus type 2 (DMT2) and hyperuricemia are two prevalent metabolic diseases worldwide, including in Indonesia. In fact, in the Minahasa tribe, the prevalence of these diseases is among the highest in Indonesia. The interaction between hyperuricemia and DMT2 level is inconclusive, as previous studies about whether allopurinol and its related uric acid reduction correlate with insulin resistance have shown conflicting results. Objective : To examine whether allopurinol-induced uric acid reduction can modify insulin resistance in nondiabetic Minahasan male subjects and study the putative molecular mechanisms of this interaction. Methods : The clinical part of this research was a pseudo-experiment with a pre-test/post-test design. Twenty nondiabetic Minahasan male subjects were subjected to the daily dose of 300 mg allopurinol for three months. Plasma glucose, uric acid, and insulin levels were measured pre- and post-treatment. Homeostatic model assessment of insulin resistance (HOMA-ir) values were calculated by the Oxford HOMA calculator. For the wet lab experiment, the human embryonic kidney cell line was treated with tolerable allopurinol. The expression of glucose transporter 4 (Glut4) mRNA, an insulin-inducible glucose transporter was analyzed by quantitative real-time polymerase chain reaction (qPCR). Results : In nondiabetic Minahasan male subjects, allopurinol administration decreased uric acid serum level, but did not affect plasma glucose and insulin levels. In fact, there is a trend of increasing HOMA-ir among the subjects following allopurinol administration. In vitro , allopurinol treatment also did not increase Glut4 expression, suggesting that allopurinol's effect on diabetes control has other, complex mediative pathways. Conclusion : Allopurinol administration and its related uric acid plasma reduction does not significantly affect insulin resistance; a trend however exists that allopurinol and uric acid reduction increased HOMA-ir. At the molecular level, Glut4 expression is not affected by allopurinol. }, issn = {2503-2178}, doi = {10.14710/jbtr.v10i3.22185}, url = {https://ejournal2.undip.ac.id/index.php/jbtr/article/view/22185} }
Refworks Citation Data :
Background: Diabetes mellitus type 2 (DMT2) and hyperuricemia are two prevalent metabolic diseases worldwide, including in Indonesia. In fact, in the Minahasa tribe, the prevalence of these diseases is among the highest in Indonesia. The interaction between hyperuricemia and DMT2 level is inconclusive, as previous studies about whether allopurinol and its related uric acid reduction correlate with insulin resistance have shown conflicting results.
Objective: To examine whether allopurinol-induced uric acid reduction can modify insulin resistance in nondiabetic Minahasan male subjects and study the putative molecular mechanisms of this interaction.
Methods: The clinical part of this research was a pseudo-experiment with a pre-test/post-test design. Twenty nondiabetic Minahasan male subjects were subjected to the daily dose of 300 mg allopurinol for three months. Plasma glucose, uric acid, and insulin levels were measured pre- and post-treatment. Homeostatic model assessment of insulin resistance (HOMA-ir) values were calculated by the Oxford HOMA calculator. For the wet lab experiment, the human embryonic kidney cell line was treated with tolerable allopurinol. The expression of glucose transporter 4 (Glut4) mRNA, an insulin-inducible glucose transporter was analyzed by quantitative real-time polymerase chain reaction (qPCR).
Results: In nondiabetic Minahasan male subjects, allopurinol administration decreased uric acid serum level, but did not affect plasma glucose and insulin levels. In fact, there is a trend of increasing HOMA-ir among the subjects following allopurinol administration. In vitro, allopurinol treatment also did not increase Glut4 expression, suggesting that allopurinol's effect on diabetes control has other, complex mediative pathways.
Conclusion: Allopurinol administration and its related uric acid plasma reduction does not significantly affect insulin resistance; a trend however exists that allopurinol and uric acid reduction increased HOMA-ir. At the molecular level, Glut4 expression is not affected by allopurinol.
Article Metrics:
Last update:
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Journal of Biomedicine and Translational Research Diponegoro University as publisher of the journal.
Copyright encompasses non-exclusive rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations.
Journal of Biomedicine and Translational Research Diponegoro University, the Editors and the Advisory International Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in the Journal of Biomedicine and Translational Research Diponegoro University (JBTR) are sole and exclusive responsibility of their respective authors and advertisers.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form JBTR]
The copyright form should be signed originally and send to the Editorial Office in the form of original mail, scanned document or fax : Journal of Biomedicine and Translational Research Faculty of Medicine, Diponegoro UniversityJl. Prof. Soedarto, Kampus UNDIP Tembalang, Semarang, Central Java, Indonesia 50275, Telp.: +62-24-8454714, Fax.: +62-24-8454714Email: jbtr@fk.undip.ac.id
JBTR by https://ejournal2.undip.ac.id/index.php/jbtr is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
View My Stats
